brivaracetam
- Product NDC
- 50228-559
- Requested package NDC
- 50228-559-10
- 11-digit product format
- 502280559
- Labeler code
- 50228
- Product ID
- 50228-559_193abd80-412f-44b3-8dc7-1c47011c58b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brivaracetam
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Application
- ANDA219952
- Marketing category
- ANDA
- Marketing start
- 2026-03-27
- Substance
- BRIVARACETAM
- Active strength
- 75 mg/1
- Pharmacologic classes
- Epoxide Hydrolase Inhibitors [MoA]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219952-001 | BRIVARACETAM | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | |
| A219952-002 | BRIVARACETAM | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | |
| A219952-003 | BRIVARACETAM | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | |
| A219952-004 | BRIVARACETAM | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | |
| A219952-005 | BRIVARACETAM | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219952-001 | AB |
| A219952-002 | AB |
| A219952-003 | AB |
| A219952-004 | AB |
| A219952-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219952-001 | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219952-002 | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219952-003 | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219952-004 | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219952-005 | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A219952-001 | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219952-002 | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219952-003 | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219952-004 | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219952-005 | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A219952-001 | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219952-002 | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219952-003 | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219952-004 | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219952-005 | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219952-001 | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219952-002 | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219952-003 | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219952-004 | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219952-005 | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-001 | BRIVARACETAM | 10MG | TABLET / ORAL | AB | 2026-07-01 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-002 | BRIVARACETAM | 25MG | TABLET / ORAL | AB | 2026-07-01 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-003 | BRIVARACETAM | 50MG | TABLET / ORAL | AB | 2026-07-01 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-004 | BRIVARACETAM | 75MG | TABLET / ORAL | AB | 2026-07-01 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-005 | BRIVARACETAM | 100MG | TABLET / ORAL | AB | 2026-07-01 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219952-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219952-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219952-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219952-004 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219952-005 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A219952-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219952-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219952-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219952-004 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219952-005 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A219952-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219952-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219952-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219952-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219952-005 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219952-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219952-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219952-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219952-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219952-005 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-004 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219952-005 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- brivaracetam
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BRIVARACETAM | 75 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U863JGG2IA | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bdbb6756-654c-46f1-a85c-7d5d1a89685a | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRIVARACETAM | BRIVARACETAM | Exelan Pharmaceuticals, Inc | bf372f42-cfc9-4fcf-8226-3936ba8833d7 | 2026-09-25 | Warnings, Adverse reactions | 219952 ANDA219952 |
| brivaracetam | BRIVARACETAM | ScieGen Pharmaceuticals, Inc. | bdbb6756-654c-46f1-a85c-7d5d1a89685a | 2026-07-23 | Warnings, Adverse reactions | 219952 ANDA219952 50228-559-10 50228-559 50228055910 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 50228-559-10 | 50228055910 | 1000 TABLET, FILM COATED in 1 BOTTLE (50228-559-10) | 2026-03-27 | No | No | Current |